Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice

It has been 45 years since Gunther Schlager used a cross breeding program in mice to develop inbred strains with high, normal, and low blood pressure (BPH/2, BPN/3, and BPL/1 respectively). Thus, it is timely to gather together the studies that have characterized and explored the mechanisms associat...

Full description

Bibliographic Details
Main Authors: Kristy L. Jackson, Geoffrey A. Head, Cindy Gueguen, Emily R. Stevenson, Kyungjoon Lim, Francine Z. Marques
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2019.01311/full
_version_ 1819102957624360960
author Kristy L. Jackson
Geoffrey A. Head
Cindy Gueguen
Emily R. Stevenson
Kyungjoon Lim
Kyungjoon Lim
Francine Z. Marques
Francine Z. Marques
author_facet Kristy L. Jackson
Geoffrey A. Head
Cindy Gueguen
Emily R. Stevenson
Kyungjoon Lim
Kyungjoon Lim
Francine Z. Marques
Francine Z. Marques
author_sort Kristy L. Jackson
collection DOAJ
description It has been 45 years since Gunther Schlager used a cross breeding program in mice to develop inbred strains with high, normal, and low blood pressure (BPH/2, BPN/3, and BPL/1 respectively). Thus, it is timely to gather together the studies that have characterized and explored the mechanisms associated with the hypertension to take stock of exactly what is known and what remains to be determined. Growing evidence supports the notion that the mechanism of hypertension in BPH/2 mice is predominantly neurogenic with some of the early studies showing aberrant brain noradrenaline levels in BPH/2 compared with BPN/3. Analysis of the adrenal gland using microarray suggested an association with the activity of the sympathetic nervous system. Indeed, in support of this, there is a larger depressor response to ganglion blockade, which reduced blood pressure in BPH/2 mice to the same level as BPN/3 mice. Greater renal tyrosine hydroxylase staining and greater renal noradrenaline levels in BPH/2 mice suggest sympathetic hyperinnervation of the kidney. Renal denervation markedly reduced the blood pressure in BPH/2 but not BPN/3 mice, confirming the importance of renal sympathetic nervous activity contributing to the hypertension. Further, there is an important contribution to the hypertension from miR-181a and renal renin in this strain. BPH/2 mice also display greater neuronal activity of amygdalo-hypothalamic cardiovascular regulatory regions. Lesions of the medial nucleus of the amygdala reduced the hypertension in BPH/2 mice and abolished the strain difference in the effect of ganglion blockade, suggesting a sympathetic mechanism. Further studies suggest that aberrant GABAergic inhibition may play a role since BPH/2 mice have low GABAA receptor δ, α4 and β2 subunit mRNA expression in the hypothalamus, which are predominantly involved in promoting tonic neuronal inhibition. Allopregnanolone, an allosteric modulator of GABAA receptors, which increase the expression of these subunits in the amygdala and hypothalamus, is shown to reduce the hypertension and sympathetic nervous system contribution in BPH/2 mice. Thus far, evidence suggests that BPH/2 mice have aberrant GABAergic inhibition, which drives neuronal overactivity within amygdalo-hypothalamic brain regions. This overactivity is responsible for the greater sympathetic contribution to the hypertension in BPH/2 mice, thus making this an ideal model of neurogenic hypertension.
first_indexed 2024-12-22T01:42:49Z
format Article
id doaj.art-41885f8304da4333a475d0a2f55b216c
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-22T01:42:49Z
publishDate 2019-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-41885f8304da4333a475d0a2f55b216c2022-12-21T18:43:09ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-10-011010.3389/fphys.2019.01311494675Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 MiceKristy L. Jackson0Geoffrey A. Head1Cindy Gueguen2Emily R. Stevenson3Kyungjoon Lim4Kyungjoon Lim5Francine Z. Marques6Francine Z. Marques7Neuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaNeuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaNeuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaNeuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaNeuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaDepartment of Physiology, Anatomy and Microbiology, School of Life Sciences, La Trobe University, Melbourne, VIC, AustraliaNeuropharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, AustraliaHypertension Research Laboratory, School of Biological Sciences, Monash University, Clayton, VIC, AustraliaIt has been 45 years since Gunther Schlager used a cross breeding program in mice to develop inbred strains with high, normal, and low blood pressure (BPH/2, BPN/3, and BPL/1 respectively). Thus, it is timely to gather together the studies that have characterized and explored the mechanisms associated with the hypertension to take stock of exactly what is known and what remains to be determined. Growing evidence supports the notion that the mechanism of hypertension in BPH/2 mice is predominantly neurogenic with some of the early studies showing aberrant brain noradrenaline levels in BPH/2 compared with BPN/3. Analysis of the adrenal gland using microarray suggested an association with the activity of the sympathetic nervous system. Indeed, in support of this, there is a larger depressor response to ganglion blockade, which reduced blood pressure in BPH/2 mice to the same level as BPN/3 mice. Greater renal tyrosine hydroxylase staining and greater renal noradrenaline levels in BPH/2 mice suggest sympathetic hyperinnervation of the kidney. Renal denervation markedly reduced the blood pressure in BPH/2 but not BPN/3 mice, confirming the importance of renal sympathetic nervous activity contributing to the hypertension. Further, there is an important contribution to the hypertension from miR-181a and renal renin in this strain. BPH/2 mice also display greater neuronal activity of amygdalo-hypothalamic cardiovascular regulatory regions. Lesions of the medial nucleus of the amygdala reduced the hypertension in BPH/2 mice and abolished the strain difference in the effect of ganglion blockade, suggesting a sympathetic mechanism. Further studies suggest that aberrant GABAergic inhibition may play a role since BPH/2 mice have low GABAA receptor δ, α4 and β2 subunit mRNA expression in the hypothalamus, which are predominantly involved in promoting tonic neuronal inhibition. Allopregnanolone, an allosteric modulator of GABAA receptors, which increase the expression of these subunits in the amygdala and hypothalamus, is shown to reduce the hypertension and sympathetic nervous system contribution in BPH/2 mice. Thus far, evidence suggests that BPH/2 mice have aberrant GABAergic inhibition, which drives neuronal overactivity within amygdalo-hypothalamic brain regions. This overactivity is responsible for the greater sympathetic contribution to the hypertension in BPH/2 mice, thus making this an ideal model of neurogenic hypertension.https://www.frontiersin.org/article/10.3389/fphys.2019.01311/fullneurogenic hypertensionallopregnanoloneorexinGABA receptor Aamygdalahypothalamus
spellingShingle Kristy L. Jackson
Geoffrey A. Head
Cindy Gueguen
Emily R. Stevenson
Kyungjoon Lim
Kyungjoon Lim
Francine Z. Marques
Francine Z. Marques
Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
Frontiers in Physiology
neurogenic hypertension
allopregnanolone
orexin
GABA receptor A
amygdala
hypothalamus
title Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
title_full Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
title_fullStr Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
title_full_unstemmed Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
title_short Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice
title_sort mechanisms responsible for genetic hypertension in schlager bph 2 mice
topic neurogenic hypertension
allopregnanolone
orexin
GABA receptor A
amygdala
hypothalamus
url https://www.frontiersin.org/article/10.3389/fphys.2019.01311/full
work_keys_str_mv AT kristyljackson mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT geoffreyahead mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT cindygueguen mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT emilyrstevenson mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT kyungjoonlim mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT kyungjoonlim mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT francinezmarques mechanismsresponsibleforgenetichypertensioninschlagerbph2mice
AT francinezmarques mechanismsresponsibleforgenetichypertensioninschlagerbph2mice